Steward Partners Investment Advisory, LLC Vbi Vaccines Inc Transaction History

Steward Partners Investment Advisory, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.29 - $0.64 $57 - $128	-200 Reduced 0.34%	59,000 $17,000
Q4 2022 Feb 15, 2023	SELL	$0.38 - $22.5 $7,866 - $465,750	-20,700 Reduced 25.91%	59,200 $23,000
Q3 2022 Nov 10, 2022	SELL	$0.73 - $23.4 $1,460 - $46,800	-2,000 Reduced 2.44%	79,900 $56,000
Q2 2022 Aug 04, 2022	BUY	$0.66 - $1.81 $2,369 - $6,497	3,590 Added 4.58%	81,900 $66,000
Q1 2022 May 02, 2022	SELL	$1.27 - $2.47 $2,621 - $5,098	-2,064 Reduced 2.57%	78,310 $130,000
Q4 2021 Feb 08, 2022	SELL	$2.21 - $3.22 $76,947 - $112,113	-34,818 Reduced 30.23%	80,374 $188,000
Q3 2021 Nov 12, 2021	SELL	$2.8 - $3.72 $35,000 - $46,500	-12,500 Reduced 9.79%	115,192 $358,000
Q2 2021 Aug 13, 2021	SELL	$2.61 - $4.17 $142,245 - $227,265	-54,500 Reduced 29.91%	127,692 $428,000
Q1 2021 May 14, 2021	BUY	$2.91 - $4.32 $159,904 - $237,384	54,950 Added 43.19%	182,192 $566,000
Q4 2020 Feb 11, 2021	BUY	$2.15 - $3.5 $38,353 - $62,436	17,839 Added 16.31%	127,242 $350,000
Q3 2020 Oct 30, 2020	BUY	$2.77 - $6.17 $125,766 - $280,136	45,403 Added 70.94%	109,403 $313,000
Q2 2020 Aug 06, 2020	BUY	$0.87 - $3.13 $55,680 - $200,320	64,000 New	64,000 $198,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.